ENTRY       D07082                      Drug
NAME        Dabigatran etexilate mesylate (USAN);
            Dabigatran etexilate methanesulfonate (JAN);
            Dabigatran etexilate mesilate;
            Pradaxa (TN)
PRODUCT     PRADAXA (A-S Medication Solutions)
            PRADAXA (Boehringer Ingelheim Pharmaceuticals)
            PRADAXA (Boehringer Ingelheim Pharmaceuticals)
            PRADAXA (Bryant Ranch Prepack)
  GENERIC   DABIGATRAN ETEXILATE (American Health Packaging)
            DABIGATRAN ETEXILATE (Ascend Laboratories)
            DABIGATRAN ETEXILATE (Camber Pharmaceuticals)
FORMULA     C34H41N7O5. CH4SO3
EXACT_MASS  723.305
MOL_WEIGHT  723.8389
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01511  Thrombin inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
REMARK      Therapeutic category: 3339
            ATC code: B01AE07
            Chemical structure group: DG00164
            Product (DG00164): D07082<JP/US>
EFFICACY    Anticoagulant, Thrombin inhibitor
COMMENT     Active form of prodrug: Dabigatran [DR:D09707]
            Deep vein thrombosis after surgery, venous thromboembolic events, stroke prevention in atrial fibrillation
TARGET      F2 [HSA:2147] [KO:K01313]
  PATHWAY   hsa04080(2147)  Neuroactive ligand-receptor interaction
            hsa04610(2147)  Complement and coagulation cascades
METABOLISM  Transporter: ABCB1 [HSA:5243]
INTERACTION  
STR_MAP     map07049  Antithrombosis agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AE Direct thrombin inhibitors
                 B01AE07 Dabigatran etexilate
                  D07082  Dabigatran etexilate mesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Anticoagulants
               Direct Thrombin Inhibitors
                Dabigatran
                 D07082  Dabigatran etexilate mesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               333  Anticoagulants
                3339  Others
                 D07082  Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01511  Thrombin inhibitor
                DG00164  Dabigatran
                 D07082  Dabigatran etexilate mesylate
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00164  Dabigatran
                D07082  Dabigatran etexilate mesylate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                F2
                 D07082  Dabigatran etexilate mesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D07082
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07082
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07082
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07082
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D07082
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01511  Thrombin inhibitor
                DG00164  Dabigatran
             Transporter substrate
              DG01665  ABCB1 substrate
               DG00164  Dabigatran
DBLINKS     CAS: 872728-81-9
            PubChem: 51091424
            LigandBox: D07082
ATOM        51
            1   C1b C    24.1160  -15.2681
            2   C1a C    25.3344  -15.9715
            3   O7a O    22.8977  -15.9715
            4   C7a C    21.6964  -15.2777
            5   C1b C    20.5032  -15.9666
            6   C1b C    19.3061  -15.2752
            7   N1c N    18.1108  -15.9653
            8   C5a C    16.9148  -15.2746
            9   C8y C    15.7190  -15.9650
            10  O5a O    16.9148  -13.8614
            11  C8x C    14.5234  -15.2744
            12  C8y C    13.3048  -15.9776
            13  C8y C    13.3046  -17.3845
            14  C8x C    14.5004  -18.0750
            15  C8x C    15.7188  -17.3718
            16  O6a O    21.6963  -13.8615
            17  N5x N    11.9669  -15.5428
            18  C8y C    11.1398  -16.6807
            19  N4y N    11.9666  -17.8191
            20  C1a C    11.5351  -19.1457
            21  C1b C     9.7662  -16.6804
            22  N1b N     9.0649  -17.8945
            23  C8y C     7.6561  -17.8942
            24  C8x C     6.9427  -16.6582
            25  C8x C     5.5358  -16.6580
            26  C8y C     4.8323  -17.8763
            27  C8x C     5.5457  -19.1124
            28  C8x C     6.9526  -19.1125
            29  C2c C     3.4354  -17.8761
            30  N1a N     2.7342  -19.0904
            31  N2b N     2.7297  -16.6536
            32  C7a C     3.4247  -15.4505
            33  O7a O     4.8419  -15.4506
            34  O6a O     2.7365  -14.2582
            35  C1b C     5.5334  -14.2538
            36  C1b C     6.9522  -14.2539
            37  C1b C     7.6433  -13.0578
            38  C1b C     9.0625  -13.0579
            39  C1b C     9.7534  -11.8618
            40  C1a C    11.1728  -11.8619
            41  C8y C    18.1200  -17.3710
            42  N5x N    16.9307  -18.0683
            43  C8x C    16.9400  -19.4691
            44  C8x C    18.1577  -20.1613
            45  C8x C    19.3471  -19.4640
            46  C8x C    19.3377  -18.0633
            47  S4a S    31.0083  -15.9012
            48  O1d O    31.0091  -17.3080
            49  O1d O    30.9780  -14.4946
            50  O1d O    32.4150  -15.8856
            51  C1a C    29.6015  -15.9168
BOND        53
            1     1   2 1
            2     1   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     8  10 2
            10    9  11 2
            11   11  12 1
            12   12  13 2
            13   13  14 1
            14   14  15 2
            15    9  15 1
            16    4  16 2
            17   12  17 1
            18   17  18 2
            19   18  19 1
            20   13  19 1
            21   19  20 1
            22   18  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 2
            26   24  25 1
            27   25  26 2
            28   26  27 1
            29   27  28 2
            30   23  28 1
            31   26  29 1
            32   29  30 1
            33   29  31 2
            34   31  32 1
            35   32  33 1
            36   32  34 2
            37   33  35 1
            38   35  36 1
            39   36  37 1
            40   37  38 1
            41   38  39 1
            42   39  40 1
            43    7  41 1
            44   41  42 2
            45   42  43 1
            46   43  44 2
            47   44  45 1
            48   45  46 2
            49   41  46 1
            50   47  48 2
            51   47  49 2
            52   47  50 1
            53   47  51 1
///
